Basic Biopharmaceutics Workshop
Develop your knowledge on core theoretical principles and the application of biopharmaceutics to aid progression of oral drug development projects.
The APS is pleased to announce a unique opportunity of a one-day workshop focused on oral biopharmaceutics and the science of oral absorption delivered by a mix of industrial and academic experts in oral biopharmaceutics with many years of experience.
Topics covered include
- Basic fundamental principles of oral biopharmaceutics
- Impact of small molecule physicochemical properties
- Biopharmaceutical properties on oral bioavailability
- Gastrointestinal physiology
- Basic pharmacokinetics principles
- Biopharmaceutical Classification System, Developability Classification System
- Biomodelling tools to predict oral absorption
- Regulatory biopharmaceutics
Speakers are from large pharma, biotechnology companies, contract research organisations, University of Strathclyde, University of Huddersfield and the University of Bath.
There will be many opportunities to network and talk with the speakers. A discussion in a round table format will allow attendees the opportunity to question how biopharmaceutics data can be used to define key risks for oral product design and development and to define current gaps and future challenges.
0830 Registration and coffee
0920 Welcome, Introductions and Biopharmaceutics Basics Nikoletta Fotaki, University of Bath
0940 Physicochemical Properties for Biopharmaceutics Speaker: Ibrahim Khadra, University of Strathclyde
1020 Biopharmaceutical Properties (e.g Permeability) Speaker: Chris Roe, Quotient
1100 Tea & coffee
1120 Dissolution Speaker: Nikoletta Fotaki, University of Bath
1200 Gastrointestinal Physiology Speaker: Mark McAllister, Pfizer
1340 Basic Pharmacokinetics Principles Speaker: Hamid Merchant, University of Huddersfield
1420 Biopharmaceutics classification systems in drug development (BCS, BDDCS, DCS) Speaker: James Butler, GSK
1500 Tea & coffee
1520 Biomodels and simulations Speaker: Jonathan Brown, BMS
1600 Regulatory Biopharmaceutics Speaker: Shanoo Budhdeo, SEDA
1640 Discussion: Future challenges
1720 Closing remarks